Table 4.
Safety profile and side effects (grade 3 or 4) n (%)
| Toxicities | Adjuvant group, n = 25 (100) | Neoadjuvant group, n = 13 (100) |
| Abdominal pain/pelvic pain | 16 (64) | 5 (38.5) |
| Nausea/vomiting | 9 (36) | 4 (30.8) |
| Fatigue | 2 (8) | 2 (15.4) |
| Renal insufficiency | 0 (0) | 3 (23.1) |
| Dehydration/hypotension | 4 (16) | 2 (15.4) |
| Catheter malfunction/infection | 1 (4) | 0 (0) |
| Anemia | 3 (12) | 1 (7.7) |
| Thrombocytopenia | 1 (4) | 0 (0) |
| Neutropenia | 5 (20) | 1 (7.7) |
| Hypokalemia | 1 (4) | 4 (30.8) |
| Hypomagnesemia | 3 (12) | 2 (15.4) |